132312-62-0 Usage
Chemical structure
P4MP2O consists of a pyrrolidin-2-one ring with a pyridine moiety attached to the carbon at position 1.
Classification
It is a heterocyclic compound.
Pharmaceutical applications
P4MP2O has potential pharmaceutical applications, particularly in the field of drug development.
GABA(A) receptor modulator
P4MP2O has been studied for its potential as a GABA(A) receptor positive allosteric modulator.
Neurological disorders
Due to its potential as a GABA(A) receptor modulator, P4MP2O could be useful in the treatment of certain neurological disorders.
Anti-inflammatory potential
The compound has been investigated for its potential as an anti-inflammatory agent.
Analgesic potential
P4MP2O has also been studied for its potential as an analgesic agent.
Research interest
Its unique structure and potential biological activities make P4MP2O an interesting target for further research and potential drug development.
Check Digit Verification of cas no
The CAS Registry Mumber 132312-62-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,2,3,1 and 2 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 132312-62:
(8*1)+(7*3)+(6*2)+(5*3)+(4*1)+(3*2)+(2*6)+(1*2)=80
80 % 10 = 0
So 132312-62-0 is a valid CAS Registry Number.
132312-62-0Relevant articles and documents
A novel and efficient synthesis of a tetra-substituted imidazole
Hayes,Hayes, Jerome F.,Mitchell,Mitchell, Michael B.,Procter,Procter, Carry
, p. 273 - 274 (2007/10/02)
A novel synthesis of a tetra-substituted imidazole is described. A key feature of the synthesis is the regioselective deprotonation of picolylpyrrolidinone 3 and the efficient reaction of this anion with an aryl nitrile to give the pyrrolidinoimidazole nu
Process for large-scale production of BMY 21502
-
, (2008/06/13)
An improved process, suitable for adaption to large-scale manufacture for synthesis of the cerebral function enhancing agent BMY 21502.